Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of Inventions Concerning an Inactivated Dengue Virus Vaccine and a Method and Kit for Detection of Dengue Virus, 80798 [2010-32235]

Download as PDF 80798 Federal Register / Vol. 75, No. 246 / Thursday, December 23, 2010 / Notices contacting Kim Iverson, Public Information Officer, South Atlantic Fishery Management Council, 4055 Faber Place Drive, Suite 201, North Charleston, SC 29405; telephone: (843) 571–4366 or toll free at (866) SAFMC– 10. Copies will also be available online at https://www.safmc.net as they become available. Special Accommodations These meetings are physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aids should be directed to the Council office (see ADDRESSES) 3 days prior to the start of each meeting. Dated: December 17, 2010. Tracey L. Thompson, Acting Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2010–32217 Filed 12–22–10; 8:45 am] BILLING CODE 3510–22–P DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration RIN 0648–XA106 New England Fishery Management Council; Public Meeting National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce. ACTION: Notice; public meeting. AGENCY: The New England Fishery Management Council’s (Council) Groundfish Committee will meet to consider actions affecting New England fisheries in the exclusive economic zone (EEZ). DATES: The meeting will be held on Wednesday, January 19, 2011 at 9 a.m. ADDRESSES: The meeting will be held at the Clarion Hotel, 1230 Congress Street, Portland, ME 04102; telephone: (207) 774–5611; fax: (207) 871–0510. Council address: New England Fishery Management Council, 50 Water Street, Mill 2, Newburyport, MA 01950. FOR FURTHER INFORMATION CONTACT: Paul J. Howard, Executive Director, New England Fishery Management Council; telephone: (978) 465–0492. SUPPLEMENTARY INFORMATION: The items of discussion in the committee’s agenda are as follows: The Multispecies (Groundfish) Oversight Committee will begin development of Framework 47 to the Northeast Multispecies Fishery Management Plan (FMP). Framework 47 mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 18:06 Dec 22, 2010 Jkt 223001 will consider changes to the haddock bycatch cap in the herring fishery. The Committee will work on the development of an amendment to the FMP that will address issues related to state-sponsored permit banks. The Committee will also discuss the initiation of an amendment to the FMP to consider allocative effects, excessive control of fishing privileges, and fleet diversity objectives for the multispecies fishery. Other business may also be discussed. The Committee’s recommendations will be delivered to the full Council at its meeting in Portsmouth, NH on January 25–27, 2011. Although non-emergency issues not contained in this agenda may come before this group for discussion, those issues may not be the subject of formal action during this meeting. Action will be restricted to those issues specifically identified in this notice and any issues arising after publication of this notice that require emergency action under section 305(c) of the Magnuson-Stevens Fishery Conservation and Management Act, provided the public has been notified of the Council’s intent to take final action to address the emergency. Special Accommodations This meeting is physically accessible to people with disabilities. Requests for sign language interpretation or other auxiliary aids should be directed to Paul J. Howard (see ADDRESSES) at least 5 days prior to the meeting date. Authority: 16 U.S.C. 1801 et seq. Dated: December 17, 2010. Tracey L. Thompson, Acting Director, Office of Sustainable Fisheries, National Marine Fisheries Service. [FR Doc. 2010–32215 Filed 12–22–10; 8:45 am] BILLING CODE 3510–22–P Availability for Exclusive, NonExclusive, or Partially-Exclusive Licensing of Inventions Concerning an Inactivated Dengue Virus Vaccine and a Method and Kit for Detection of Dengue Virus Department of the Army, DoD. Notice. AGENCY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent 6,254,873 which issued July 3, 2001, entitled ‘‘Inactivated Dengue Virus Vaccine,’’ and U.S. Patent 6,190,859, entitled ‘‘Method and Kit for Detection PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2010–32235 Filed 12–22–10; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Intent To Prepare a Programmatic Environmental Impact Statement (PEIS) for Land Acquisition, South Texas Training Center (STTC), in McMullen County, TX National Guard Bureau, Department of the Army, DoD. ACTION: Notice of intent. Department of the Army SUMMARY: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to an inactivated dengue virus vaccine to immunize and protect humans against dengue fever. The vaccine is based on dengue viruses which have been propagated to high titers in suitable cells, purified and inactivated under conditions which destroy infectivity but preserve immunogenicity, a high level of which is demonstrated in animal models. Uses of the inactivated dengue virus for detecting antibodies to dengue and kits therefore are also described. FOR FURTHER INFORMATION CONTACT: AGENCY: DEPARTMENT OF DEFENSE ACTION: of Dengue Virus,’’ issued February 20, 2001. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. The Department of the Army intends to prepare a PEIS to analyze the environmental and socioeconomic impacts associated with the proposed land acquisition and use of approximately 22,232 acres for implementation of an RPMP and mission activities in south Texas. The proposed land area, currently in private ownership, would become the STTC. This action will support the training requirements of the TXARNG units located in central and south Texas. The PEIS will analyze alternatives that are deemed feasible to meet the purpose and need for this Proposed Action. SUMMARY: E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 75, Number 246 (Thursday, December 23, 2010)]
[Notices]
[Page 80798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32235]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Exclusive, Non-Exclusive, or Partially-Exclusive 
Licensing of Inventions Concerning an Inactivated Dengue Virus Vaccine 
and a Method and Kit for Detection of Dengue Virus

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Patent 6,254,873 which issued July 3, 2001, 
entitled ``Inactivated Dengue Virus Vaccine,'' and U.S. Patent 
6,190,859, entitled ``Method and Kit for Detection of Dengue Virus,'' 
issued February 20, 2001. The United States Government, as represented 
by the Secretary of the Army, has rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to an inactivated 
dengue virus vaccine to immunize and protect humans against dengue 
fever. The vaccine is based on dengue viruses which have been 
propagated to high titers in suitable cells, purified and inactivated 
under conditions which destroy infectivity but preserve immunogenicity, 
a high level of which is demonstrated in animal models. Uses of the 
inactivated dengue virus for detecting antibodies to dengue and kits 
therefore are also described.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-32235 Filed 12-22-10; 8:45 am]
BILLING CODE 3710-08-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.